Counterpoint Global is one of Morgan Stanley's fundamental equity teams that aims to make long-term investments.
Counterpoint Global is one of Morgan Stanley's fundamental equity teams that aims to make long-term investments in unique companies. The culture of the team promotes collaboration, creativity, ongoing development, and differentiated thinking. Company portfolios are normally concentrated and differentiated from their benchmarks. Counterpoint Global is made up of 35 individuals, including 18 investment professionals and two disruptive change researchers.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 20, 2021
![]() |
Series C | $110M | Blockchain | — |
Dec 8, 2021
![]() |
Series F | $270M | Accounting | — |
Dec 2, 2021
![]() |
Post-IPO Equity | $4B | Apps | — |
Sep 1, 2021
![]() |
Post-IPO Equity | $375M | Biotechnology | — |
Aug 31, 2021
![]() |
Series H | $1.60B | Analytics | Yes |